gap43 intracellular growth protein membrane protein Search Results


97
Thermo Fisher gene exp gap43 hs00967138 m1
Gene Exp Gap43 Hs00967138 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp gap43 hs00967138 m1/product/Thermo Fisher
Average 97 stars, based on 1 article reviews
gene exp gap43 hs00967138 m1 - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

96
New England Biolabs wild type full length gap 43 rna
Wild Type Full Length Gap 43 Rna, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wild type full length gap 43 rna/product/New England Biolabs
Average 96 stars, based on 1 article reviews
wild type full length gap 43 rna - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Boehringer Mannheim gap-43 antibody
Gap 43 Antibody, supplied by Boehringer Mannheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gap-43 antibody/product/Boehringer Mannheim
Average 90 stars, based on 1 article reviews
gap-43 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology protein 43 gap43
Fig. 3. The expression of miR-338-5p was lower in the rats with SCI than the control rats, and the miR- 338-5p-overexpressing exosomes provided neuro protective effects after SCI. (A) Expression of miR- 338-5p was assessed by qRT-PCR at 1, 4 and 7 days after acute spinal cord injury in rats. (B, C) Western blot analysis of NF-M, <t>GAP43,</t> MAG and GFAP levels following various treatments at day 4 post-SCI. Data are presented as the mean ± SD. n = 4 per group (A), n = 3 per group (C), #p < 0.05, ##p < 0.01, *p < 0.05, **p < 0.01, ***p < 0.001.
Protein 43 Gap43, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein 43 gap43/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
protein 43 gap43 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
Millipore anti-gap-43
Fig. 3. The expression of miR-338-5p was lower in the rats with SCI than the control rats, and the miR- 338-5p-overexpressing exosomes provided neuro protective effects after SCI. (A) Expression of miR- 338-5p was assessed by qRT-PCR at 1, 4 and 7 days after acute spinal cord injury in rats. (B, C) Western blot analysis of NF-M, <t>GAP43,</t> MAG and GFAP levels following various treatments at day 4 post-SCI. Data are presented as the mean ± SD. n = 4 per group (A), n = 3 per group (C), #p < 0.05, ##p < 0.01, *p < 0.05, **p < 0.01, ***p < 0.001.
Anti Gap 43, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-gap-43/product/Millipore
Average 90 stars, based on 1 article reviews
anti-gap-43 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Thermo Fisher rabbit gap43 polyclonal antibody
Fig. 3. The expression of miR-338-5p was lower in the rats with SCI than the control rats, and the miR- 338-5p-overexpressing exosomes provided neuro protective effects after SCI. (A) Expression of miR- 338-5p was assessed by qRT-PCR at 1, 4 and 7 days after acute spinal cord injury in rats. (B, C) Western blot analysis of NF-M, <t>GAP43,</t> MAG and GFAP levels following various treatments at day 4 post-SCI. Data are presented as the mean ± SD. n = 4 per group (A), n = 3 per group (C), #p < 0.05, ##p < 0.01, *p < 0.05, **p < 0.01, ***p < 0.001.
Rabbit Gap43 Polyclonal Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit gap43 polyclonal antibody/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
rabbit gap43 polyclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

86
Danaher Inc gap 43
Fig. 3. The expression of miR-338-5p was lower in the rats with SCI than the control rats, and the miR- 338-5p-overexpressing exosomes provided neuro protective effects after SCI. (A) Expression of miR- 338-5p was assessed by qRT-PCR at 1, 4 and 7 days after acute spinal cord injury in rats. (B, C) Western blot analysis of NF-M, <t>GAP43,</t> MAG and GFAP levels following various treatments at day 4 post-SCI. Data are presented as the mean ± SD. n = 4 per group (A), n = 3 per group (C), #p < 0.05, ##p < 0.01, *p < 0.05, **p < 0.01, ***p < 0.001.
Gap 43, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gap 43/product/Danaher Inc
Average 86 stars, based on 1 article reviews
gap 43 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

93
Thermo Fisher gene exp gap43 mm00500404 m1
Fig. 3. The expression of miR-338-5p was lower in the rats with SCI than the control rats, and the miR- 338-5p-overexpressing exosomes provided neuro protective effects after SCI. (A) Expression of miR- 338-5p was assessed by qRT-PCR at 1, 4 and 7 days after acute spinal cord injury in rats. (B, C) Western blot analysis of NF-M, <t>GAP43,</t> MAG and GFAP levels following various treatments at day 4 post-SCI. Data are presented as the mean ± SD. n = 4 per group (A), n = 3 per group (C), #p < 0.05, ##p < 0.01, *p < 0.05, **p < 0.01, ***p < 0.001.
Gene Exp Gap43 Mm00500404 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp gap43 mm00500404 m1/product/Thermo Fisher
Average 93 stars, based on 1 article reviews
gene exp gap43 mm00500404 m1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Autogen-Bioclear ltd mouse anti–gap-43
Ral regulates <t>GAP-43</t> phosphorylation. (A) COS cells were transfected with the indicated myc-tagged Ral constructs and cGAP-43. Levels of phospho-cGAP-43 in cell extracts were determined by immunoblotting with an anti–phospho-GAP-43 antibody. A representative blot is shown. Inactive Ral causes a significant decrease of cGAP-43 phosphorylation (top band, arrow). (B) Quantitative analysis of phosphorylated cGAP-43 in COS cells transfected with cGAP-43 and the indicated Ral constructs. Shown here are data from four independent experiments (means ± SEM; *, P < 0.01). (C) Cortical neurons were nucleofected with the indicated constructs and lysed after overnight expression. Levels of total and phosphoendogenous GAP-43 were then assessed by immunoblotting. The fourth, fifth, and sixth lanes were derived from the same blot. (D) Quantitative analysis of endogenous GAP-43 phosphorylation in cortical neurons after nucleofection with the indicated Ral mutant isoforms. Data were derived from four independent experiments (means ± SEM; **, P < 0.005).
Mouse Anti–Gap 43, supplied by Autogen-Bioclear ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti–gap-43/product/Autogen-Bioclear ltd
Average 90 stars, based on 1 article reviews
mouse anti–gap-43 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Addgene inc pcag mgfp
Ral regulates <t>GAP-43</t> phosphorylation. (A) COS cells were transfected with the indicated myc-tagged Ral constructs and cGAP-43. Levels of phospho-cGAP-43 in cell extracts were determined by immunoblotting with an anti–phospho-GAP-43 antibody. A representative blot is shown. Inactive Ral causes a significant decrease of cGAP-43 phosphorylation (top band, arrow). (B) Quantitative analysis of phosphorylated cGAP-43 in COS cells transfected with cGAP-43 and the indicated Ral constructs. Shown here are data from four independent experiments (means ± SEM; *, P < 0.01). (C) Cortical neurons were nucleofected with the indicated constructs and lysed after overnight expression. Levels of total and phosphoendogenous GAP-43 were then assessed by immunoblotting. The fourth, fifth, and sixth lanes were derived from the same blot. (D) Quantitative analysis of endogenous GAP-43 phosphorylation in cortical neurons after nucleofection with the indicated Ral mutant isoforms. Data were derived from four independent experiments (means ± SEM; **, P < 0.005).
Pcag Mgfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcag mgfp/product/Addgene inc
Average 93 stars, based on 1 article reviews
pcag mgfp - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Proteintech i ap
Ral regulates <t>GAP-43</t> phosphorylation. (A) COS cells were transfected with the indicated myc-tagged Ral constructs and cGAP-43. Levels of phospho-cGAP-43 in cell extracts were determined by immunoblotting with an anti–phospho-GAP-43 antibody. A representative blot is shown. Inactive Ral causes a significant decrease of cGAP-43 phosphorylation (top band, arrow). (B) Quantitative analysis of phosphorylated cGAP-43 in COS cells transfected with cGAP-43 and the indicated Ral constructs. Shown here are data from four independent experiments (means ± SEM; *, P < 0.01). (C) Cortical neurons were nucleofected with the indicated constructs and lysed after overnight expression. Levels of total and phosphoendogenous GAP-43 were then assessed by immunoblotting. The fourth, fifth, and sixth lanes were derived from the same blot. (D) Quantitative analysis of endogenous GAP-43 phosphorylation in cortical neurons after nucleofection with the indicated Ral mutant isoforms. Data were derived from four independent experiments (means ± SEM; **, P < 0.005).
I Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/i ap/product/Proteintech
Average 95 stars, based on 1 article reviews
i ap - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


Fig. 3. The expression of miR-338-5p was lower in the rats with SCI than the control rats, and the miR- 338-5p-overexpressing exosomes provided neuro protective effects after SCI. (A) Expression of miR- 338-5p was assessed by qRT-PCR at 1, 4 and 7 days after acute spinal cord injury in rats. (B, C) Western blot analysis of NF-M, GAP43, MAG and GFAP levels following various treatments at day 4 post-SCI. Data are presented as the mean ± SD. n = 4 per group (A), n = 3 per group (C), #p < 0.05, ##p < 0.01, *p < 0.05, **p < 0.01, ***p < 0.001.

Journal: Neuroscience letters

Article Title: Overexpression of miR-338-5p in exosomes derived from mesenchymal stromal cells provides neuroprotective effects by the Cnr1/Rap1/Akt pathway after spinal cord injury in rats.

doi: 10.1016/j.neulet.2021.136124

Figure Lengend Snippet: Fig. 3. The expression of miR-338-5p was lower in the rats with SCI than the control rats, and the miR- 338-5p-overexpressing exosomes provided neuro protective effects after SCI. (A) Expression of miR- 338-5p was assessed by qRT-PCR at 1, 4 and 7 days after acute spinal cord injury in rats. (B, C) Western blot analysis of NF-M, GAP43, MAG and GFAP levels following various treatments at day 4 post-SCI. Data are presented as the mean ± SD. n = 4 per group (A), n = 3 per group (C), #p < 0.05, ##p < 0.01, *p < 0.05, **p < 0.01, ***p < 0.001.

Article Snippet: After the membranes were blocked with 5% nonfat milk in TBST for 1 h at room temperature, they were incubated with primary antibodies overnight at 4◦C as follows: TSG101 (1:1000, Santa Cruz Biotechnology), HSP70 (1:1000, Santa Cruz Biotechnology), CD63 (1:1000, Santa Cruz Biotechnology), CD9 (1:1000, Santa Cruz Biotechnology), Cnr1 (1:1000, Santa Cruz Biotechnology), Rap1 (1:1000, Santa Cruz Biotechnology), neurofilament-M (NF-M) (1:1000, Proteintech Group), growth associated protein-43 (GAP43) (1:1000, Santa Cruz Biotechnology), myelinassociated glycoprotein (MAG) (1:1000, Proteintech Group), glial fibrillary acidic protein (GFAP) (1:1000, Proteintech Group), Bax (1:1000, Cell Signaling Technology), Bcl-2 (1:1000, Cell Signaling Technology), pro caspase-3 (1:1000, Cell Signaling Technology), cleaved-caspase-3 (1:1000, Cell Signaling Technology), total-PI3K (1:1000, Cell Signaling Technology), p-PI3K (1:1000, Cell Signaling Technology), total-AKT (1:1000, Cell Signaling Technology), and p-AKT (1:1000, Cell Signaling Technology).

Techniques: Expressing, Control, Quantitative RT-PCR, Western Blot

Fig. 4. Immunofluorescence double staining of NF-M, GAP43, MAG and GFAP levels following various treatments at day 4 post-SCI in rats. (A) Increased levels of the NF-M and GAP43 proteins in the region of anterior horn and adjacent lateral funiculus were observed in the miR-338-5p exo group compared to the other SCI groups at day 4 post-SCI. (B) Decreased protein levels of MAG and GFAP in the region of anterior horn and adjacent lateral funiculus were observed in the miR-338-5p exo group compared to the other SCI groups at day 4 post-SCI. Scale bar, 200 µm. (C) Semi-quantification of the mean fluorescence intensity of NF-M, GAP43, MAG and GFAP were measured. Data are presented as the mean ± SD. n = 3 per group, #p < 0.05, ##p < 0.01, ###p < 0.001, *p < 0.05, **p < 0.01, ***p < 0.001.

Journal: Neuroscience letters

Article Title: Overexpression of miR-338-5p in exosomes derived from mesenchymal stromal cells provides neuroprotective effects by the Cnr1/Rap1/Akt pathway after spinal cord injury in rats.

doi: 10.1016/j.neulet.2021.136124

Figure Lengend Snippet: Fig. 4. Immunofluorescence double staining of NF-M, GAP43, MAG and GFAP levels following various treatments at day 4 post-SCI in rats. (A) Increased levels of the NF-M and GAP43 proteins in the region of anterior horn and adjacent lateral funiculus were observed in the miR-338-5p exo group compared to the other SCI groups at day 4 post-SCI. (B) Decreased protein levels of MAG and GFAP in the region of anterior horn and adjacent lateral funiculus were observed in the miR-338-5p exo group compared to the other SCI groups at day 4 post-SCI. Scale bar, 200 µm. (C) Semi-quantification of the mean fluorescence intensity of NF-M, GAP43, MAG and GFAP were measured. Data are presented as the mean ± SD. n = 3 per group, #p < 0.05, ##p < 0.01, ###p < 0.001, *p < 0.05, **p < 0.01, ***p < 0.001.

Article Snippet: After the membranes were blocked with 5% nonfat milk in TBST for 1 h at room temperature, they were incubated with primary antibodies overnight at 4◦C as follows: TSG101 (1:1000, Santa Cruz Biotechnology), HSP70 (1:1000, Santa Cruz Biotechnology), CD63 (1:1000, Santa Cruz Biotechnology), CD9 (1:1000, Santa Cruz Biotechnology), Cnr1 (1:1000, Santa Cruz Biotechnology), Rap1 (1:1000, Santa Cruz Biotechnology), neurofilament-M (NF-M) (1:1000, Proteintech Group), growth associated protein-43 (GAP43) (1:1000, Santa Cruz Biotechnology), myelinassociated glycoprotein (MAG) (1:1000, Proteintech Group), glial fibrillary acidic protein (GFAP) (1:1000, Proteintech Group), Bax (1:1000, Cell Signaling Technology), Bcl-2 (1:1000, Cell Signaling Technology), pro caspase-3 (1:1000, Cell Signaling Technology), cleaved-caspase-3 (1:1000, Cell Signaling Technology), total-PI3K (1:1000, Cell Signaling Technology), p-PI3K (1:1000, Cell Signaling Technology), total-AKT (1:1000, Cell Signaling Technology), and p-AKT (1:1000, Cell Signaling Technology).

Techniques: Immunofluorescence, Double Staining, Fluorescence

Fig. 6. Overexpression of miR-338-5p alleviated H2O2-induced cell injury in PC12 cells. (A) PC12 cells were transfected with NC mimics/inhibitors, miR-338-5p mimics and inhibitors. qRT-PCR analysis of the miR-338-5p level. (B, C) Measurement of intracellular ROS and SOD. (D) CCK-8 assay for cell viability. (E, F) Western blot analysis of NF-M, GAP43, MAG and GFAP levels following various treatments in PC12 cells. n = 3 per group, #p < 0.05, ##p < 0.01, ###p < 0.001, *p < 0.05, **p < 0.01, ***p < 0.001.

Journal: Neuroscience letters

Article Title: Overexpression of miR-338-5p in exosomes derived from mesenchymal stromal cells provides neuroprotective effects by the Cnr1/Rap1/Akt pathway after spinal cord injury in rats.

doi: 10.1016/j.neulet.2021.136124

Figure Lengend Snippet: Fig. 6. Overexpression of miR-338-5p alleviated H2O2-induced cell injury in PC12 cells. (A) PC12 cells were transfected with NC mimics/inhibitors, miR-338-5p mimics and inhibitors. qRT-PCR analysis of the miR-338-5p level. (B, C) Measurement of intracellular ROS and SOD. (D) CCK-8 assay for cell viability. (E, F) Western blot analysis of NF-M, GAP43, MAG and GFAP levels following various treatments in PC12 cells. n = 3 per group, #p < 0.05, ##p < 0.01, ###p < 0.001, *p < 0.05, **p < 0.01, ***p < 0.001.

Article Snippet: After the membranes were blocked with 5% nonfat milk in TBST for 1 h at room temperature, they were incubated with primary antibodies overnight at 4◦C as follows: TSG101 (1:1000, Santa Cruz Biotechnology), HSP70 (1:1000, Santa Cruz Biotechnology), CD63 (1:1000, Santa Cruz Biotechnology), CD9 (1:1000, Santa Cruz Biotechnology), Cnr1 (1:1000, Santa Cruz Biotechnology), Rap1 (1:1000, Santa Cruz Biotechnology), neurofilament-M (NF-M) (1:1000, Proteintech Group), growth associated protein-43 (GAP43) (1:1000, Santa Cruz Biotechnology), myelinassociated glycoprotein (MAG) (1:1000, Proteintech Group), glial fibrillary acidic protein (GFAP) (1:1000, Proteintech Group), Bax (1:1000, Cell Signaling Technology), Bcl-2 (1:1000, Cell Signaling Technology), pro caspase-3 (1:1000, Cell Signaling Technology), cleaved-caspase-3 (1:1000, Cell Signaling Technology), total-PI3K (1:1000, Cell Signaling Technology), p-PI3K (1:1000, Cell Signaling Technology), total-AKT (1:1000, Cell Signaling Technology), and p-AKT (1:1000, Cell Signaling Technology).

Techniques: Over Expression, Transfection, Quantitative RT-PCR, CCK-8 Assay, Western Blot

Ral regulates GAP-43 phosphorylation. (A) COS cells were transfected with the indicated myc-tagged Ral constructs and cGAP-43. Levels of phospho-cGAP-43 in cell extracts were determined by immunoblotting with an anti–phospho-GAP-43 antibody. A representative blot is shown. Inactive Ral causes a significant decrease of cGAP-43 phosphorylation (top band, arrow). (B) Quantitative analysis of phosphorylated cGAP-43 in COS cells transfected with cGAP-43 and the indicated Ral constructs. Shown here are data from four independent experiments (means ± SEM; *, P < 0.01). (C) Cortical neurons were nucleofected with the indicated constructs and lysed after overnight expression. Levels of total and phosphoendogenous GAP-43 were then assessed by immunoblotting. The fourth, fifth, and sixth lanes were derived from the same blot. (D) Quantitative analysis of endogenous GAP-43 phosphorylation in cortical neurons after nucleofection with the indicated Ral mutant isoforms. Data were derived from four independent experiments (means ± SEM; **, P < 0.005).

Journal: The Journal of Cell Biology

Article Title: Ral GTPases regulate neurite branching through GAP-43 and the exocyst complex

doi: 10.1083/jcb.200507061

Figure Lengend Snippet: Ral regulates GAP-43 phosphorylation. (A) COS cells were transfected with the indicated myc-tagged Ral constructs and cGAP-43. Levels of phospho-cGAP-43 in cell extracts were determined by immunoblotting with an anti–phospho-GAP-43 antibody. A representative blot is shown. Inactive Ral causes a significant decrease of cGAP-43 phosphorylation (top band, arrow). (B) Quantitative analysis of phosphorylated cGAP-43 in COS cells transfected with cGAP-43 and the indicated Ral constructs. Shown here are data from four independent experiments (means ± SEM; *, P < 0.01). (C) Cortical neurons were nucleofected with the indicated constructs and lysed after overnight expression. Levels of total and phosphoendogenous GAP-43 were then assessed by immunoblotting. The fourth, fifth, and sixth lanes were derived from the same blot. (D) Quantitative analysis of endogenous GAP-43 phosphorylation in cortical neurons after nucleofection with the indicated Ral mutant isoforms. Data were derived from four independent experiments (means ± SEM; **, P < 0.005).

Article Snippet: Antibodies used were mouse anti-RalA, rabbit anti-RalB (BD Biosciences), mouse anti–GAP-43 (Autogen Bioclear), rabbit anti–phospho(Ser41)-GAP-43 (Zymed Laboratories), rat anti–α-tubulin (Harlan), rat anti-HA (Roche), mouse anti-myc (clone 9E10), rabbit anti-myc (Research Diagnostics, Inc.), mouse anti–βIII tubulin (Sigma-Aldrich), and rabbit anti-p38 (Santa Cruz Biotechnology, Inc.).

Techniques: Transfection, Construct, Western Blot, Expressing, Derivative Assay, Mutagenesis

GAP-43 acts downstream of Ral. (A) Constitutively active Ral increases branching in neurons plated on laminin (top middle and right) compared with EGFP-F–expressing cells (top left). This effect is reduced by coexpression of cGAP-43(S42A) (middle and bottom). Shown here are cells stained with anti-myc antibody to detect mutant Ral and anti–cGAP-43. Bar, 100 μm. (B) Quantitative analysis of branching in cells injected with single Ral isoforms or with Ral and cGAP-43(S42A) (means ± SEM: GFP, 3.30 ± 0.18; RalA72L, 8.43 ± 0.97; RalA72L + cGAP-43(S42A), 3.55 ± 0.44; RalB23V, 8.88 ± 0.85; RalB23V + cGAP-43(S42A), 4.29 ± 0.41; *, P < 0.02; **, P < 0.0001).

Journal: The Journal of Cell Biology

Article Title: Ral GTPases regulate neurite branching through GAP-43 and the exocyst complex

doi: 10.1083/jcb.200507061

Figure Lengend Snippet: GAP-43 acts downstream of Ral. (A) Constitutively active Ral increases branching in neurons plated on laminin (top middle and right) compared with EGFP-F–expressing cells (top left). This effect is reduced by coexpression of cGAP-43(S42A) (middle and bottom). Shown here are cells stained with anti-myc antibody to detect mutant Ral and anti–cGAP-43. Bar, 100 μm. (B) Quantitative analysis of branching in cells injected with single Ral isoforms or with Ral and cGAP-43(S42A) (means ± SEM: GFP, 3.30 ± 0.18; RalA72L, 8.43 ± 0.97; RalA72L + cGAP-43(S42A), 3.55 ± 0.44; RalB23V, 8.88 ± 0.85; RalB23V + cGAP-43(S42A), 4.29 ± 0.41; *, P < 0.02; **, P < 0.0001).

Article Snippet: Antibodies used were mouse anti-RalA, rabbit anti-RalB (BD Biosciences), mouse anti–GAP-43 (Autogen Bioclear), rabbit anti–phospho(Ser41)-GAP-43 (Zymed Laboratories), rat anti–α-tubulin (Harlan), rat anti-HA (Roche), mouse anti-myc (clone 9E10), rabbit anti-myc (Research Diagnostics, Inc.), mouse anti–βIII tubulin (Sigma-Aldrich), and rabbit anti-p38 (Santa Cruz Biotechnology, Inc.).

Techniques: Expressing, Staining, Mutagenesis, Injection

GAP-43 acts downstream of Ral. (A) A phosphomimetic GAP-43 protein, cGAP-43(S42D), restores branching in neurons plated on laminin and expressing dominant-negative Ral. Shown here are neurons expressing EGFP-F (top left), RalA28N (top middle), or RalB28N (bottom left) and RalA28N or RalB28N and cGAP-43(S42D) (right). Cells are stained with an anti-myc antibody to detect mutant Ral and an anti–cGAP-43 antibody. Bar, 50 μm. (B) Quantitative analysis of branching in cells plated on laminin and injected with single Ral isoforms or with Ral and cGAP-43(S42D) (means ± SEM: GFP, 3.47 ± 0.37; RalA28N, 1.74 ± 0.52; RalA28N + cGAP-43(S42D), 2.42 ± 0.31; RalB28N, 1.56 ± 0.41; RalB28N + cGAP-43(S42D), 3.72 ± 0.35; *, P < 0.04; **, P < 0.001). (C) SCG neurons were plated on polyornithine, microinjected, and left to express the indicated proteins for 5 h before laminin addition. Expression of dominant-negative Ral decreases branching compared with EGFP-F–expressing cells (top, compare middle and right with left). Branching is restored in cells coexpressing cGAP-43(S42D) (middle and bottom rows). Bar, 100 μm. (D) Quantitative analysis of branching in neurons initially plated on polyornithine and injected with single Ral isoforms or with Ral and cGAP-43(S42A) before laminin addition (means ± SEM: GFP, 2.64 ± 0.35; RalA28N, 1.05 ± 0.32; RalA28N + cGAP-43(S42D), 1.82 ± 0.40; RalB28N, 1.74 ± 0.30; RalB28N + cGAP-43(S42D), 2.73 ± 0.45; **, P < 0.01).

Journal: The Journal of Cell Biology

Article Title: Ral GTPases regulate neurite branching through GAP-43 and the exocyst complex

doi: 10.1083/jcb.200507061

Figure Lengend Snippet: GAP-43 acts downstream of Ral. (A) A phosphomimetic GAP-43 protein, cGAP-43(S42D), restores branching in neurons plated on laminin and expressing dominant-negative Ral. Shown here are neurons expressing EGFP-F (top left), RalA28N (top middle), or RalB28N (bottom left) and RalA28N or RalB28N and cGAP-43(S42D) (right). Cells are stained with an anti-myc antibody to detect mutant Ral and an anti–cGAP-43 antibody. Bar, 50 μm. (B) Quantitative analysis of branching in cells plated on laminin and injected with single Ral isoforms or with Ral and cGAP-43(S42D) (means ± SEM: GFP, 3.47 ± 0.37; RalA28N, 1.74 ± 0.52; RalA28N + cGAP-43(S42D), 2.42 ± 0.31; RalB28N, 1.56 ± 0.41; RalB28N + cGAP-43(S42D), 3.72 ± 0.35; *, P < 0.04; **, P < 0.001). (C) SCG neurons were plated on polyornithine, microinjected, and left to express the indicated proteins for 5 h before laminin addition. Expression of dominant-negative Ral decreases branching compared with EGFP-F–expressing cells (top, compare middle and right with left). Branching is restored in cells coexpressing cGAP-43(S42D) (middle and bottom rows). Bar, 100 μm. (D) Quantitative analysis of branching in neurons initially plated on polyornithine and injected with single Ral isoforms or with Ral and cGAP-43(S42A) before laminin addition (means ± SEM: GFP, 2.64 ± 0.35; RalA28N, 1.05 ± 0.32; RalA28N + cGAP-43(S42D), 1.82 ± 0.40; RalB28N, 1.74 ± 0.30; RalB28N + cGAP-43(S42D), 2.73 ± 0.45; **, P < 0.01).

Article Snippet: Antibodies used were mouse anti-RalA, rabbit anti-RalB (BD Biosciences), mouse anti–GAP-43 (Autogen Bioclear), rabbit anti–phospho(Ser41)-GAP-43 (Zymed Laboratories), rat anti–α-tubulin (Harlan), rat anti-HA (Roche), mouse anti-myc (clone 9E10), rabbit anti-myc (Research Diagnostics, Inc.), mouse anti–βIII tubulin (Sigma-Aldrich), and rabbit anti-p38 (Santa Cruz Biotechnology, Inc.).

Techniques: Expressing, Dominant Negative Mutation, Staining, Mutagenesis, Injection